Bidirectional Chopper Circuit
    91.
    发明申请

    公开(公告)号:US20180254699A1

    公开(公告)日:2018-09-06

    申请号:US15756770

    申请日:2016-03-07

    CPC classification number: H02M3/155 H02M1/088 H02M1/14 H02M7/48 H02M2007/4835

    Abstract: A bidirectional chopper circuit 1 is provided with: a main power converter 11 having a first switch 21-1 and a second switch 21-2 set up so that one switch is turned off when the other switch is turned on and connected in series with each other so as to line up in a conduction direction when turned on, the terminals on both sides of the main power converter 11 on the opposite sides to the connection sides for the first switch 21-1 and the second switch 21-2 being a pair of first external connection terminals; a plurality of single-phase full-bridge power converters 22-j and a pair of second external connection terminals provided on wiring that branches from wiring connecting the first switch 21-1 and the second switch 21-2 so that one or both are connected in cascade; and an inductor 13 connected in series with the single-phase full-bridge power converters 22-j on wiring that branches from wiring connecting the first switch 21-1 and the second switch 21-2.

    MEDICINE FOR TREATING CANCER AND METHOD FOR TREATING CANCER

    公开(公告)号:US20180179544A1

    公开(公告)日:2018-06-28

    申请号:US15739617

    申请日:2016-06-02

    Inventor: Kanako NIIMORI

    Abstract: An object of the present invention is to reveal a role of a stem cell control factor including Matrin-3 in cancer exhibiting neural differentiation including small cell lung cancer, and develop a medicine useful for treating cancer and the like based on the role. Among cancers having the cancer stem cell controlling mechanism, in cancer exhibiting the differentiation potency, the peculiar balance where both of expression of a stem cell maintenance factor and expression of a differentiation promoting factor are higher as compared with normal cells is retained. Additionally, in undifferentiated cancer, the peculiar balance where expression of a stem cell maintenance factor is higher as compared with normal cells is retained. In cancer in which the cancer stem cell controlling mechanism exists, these peculiar balances of a stem cell control factor different from the balance of normal cells exist. In the medicine for treating cancer and the method for treating cancer of the present invention, proliferativeness of cancer is suppressed by breaking down this balance of a stem cell control factor.

Patent Agency Ranking